Arecor and GSK collaborate on vaccine technology
pharmafile | June 15, 2011 | News story | Manufacturing and Production, Research and Development | Arecor, GSK, vaccines
GSK is to team up with UK company Arecor to develop advanced formulations of GSK’s vaccines.
Cambridge-based Arecor has developed formulation technologies which help stabilise proteins and vaccines so that they can be used in vaccines.
Arecor’s proprietary Arestat is a patented set of tools for stabilisation which tackle the main ways in which biologics degrade. Proteins and vaccines are often fragile entities, and stability can be a major obstacle to developing new products and extending the use of existing products.
The companies say the new approaches could offer significant improvements to the administration of several vaccines in development. In return for the license to their technology, Arecor will receive milestones payments and royalties on sales.
Tom Saylor, chief executive of Arecor, said: “Arecor is pleased to work closely with one of the global leaders in vaccine products and technology. The relationship with GSK offers Arecor the potential to apply its broad-ranging expertise in biomolecule stabilisation to specific projects with GSK.”
As a simple reformulation, Arestat can be readily incorporated into standard manufacturing practice, without covalent modification of the biologic and using excipients approved for the route of delivery. Arecor is currently running feasibility programmes and licenses with many of the top pharma and biotech companies on a wide range of proteins and vaccines.
Andrew McConaghie
Related Content

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis
GSK’s Exdensur (depemokimab), a twice-yearly biological medicine, has received approval from the UK Medicines and …

Multiple myeloma treatment approved in Japan
GSK’s Blenrep (belantamab mafodotin) combinations have been approved by Japan’s Ministry of Health, Labour and …
Valneva Scotland supports local cancer charity Team Jak Foundation
Valneva Scotland, the country’s largest vaccine producer, has partnered with local West Lothian-headquartered charity, Team …






